In chronic stable angina (eflor l-assooated angina) PROCARDIA has been effective in controlled trials ol up to eight weeks duration in reducing angina frequency and increasing exercise tolerance, but continuation of sustained effectiveness and evaluation of long-term safety In these patients are Incomplete
Digitalis Administration ol PROCARDIA with digonin increased digoxin levels In nine ol twetve normal volunteers The avenge increase was 45% Another Investigator lound no increase in dlgoxhi levels in Ihlrteen patients with coronary artery disease In an uncontrolled study ol over two hundred patients with congestive heart (allure during which digoxin Mood levels were not measured, digitalis toxldty was not observed Since there have been isolated reports o> patients with elevated digoxin t«vei). il is recommended that dlgoiln levels be monitored when initialing, adjusting, and discontinuing PROCARDIA to avoid possible over-or underdigital I at I on Coumsrln anticoagulants There have been rare reports of Increased prothrombintme in patients taking coumartn anticoagulants to whom PROCAAOtA was administtred.
Cimeiidlne A study in six heallhy volunteers has shown a significant Increase in peak nlledlplne plasma tevels [80%) and area-under-the-curve (74%) alter a one wee* course of clmelidine at BOO mg pet day and nllediplne at 40 rug per day Ranitidine produced smaller, non-slgniflcant Increases 11 nifedlpine therapy Is Initiated In a [alwn currently receiving cinaldiie. cautious Illratlon Is advised. fmbaiumili. MIIUBMIII. tapalrarat el totfUty: Niledlpme was administered orally to rats lor two years and was not shown to be carcinogenic When given to rats prior lo mating, nifedlpine caused reduced fer dirty at a dose approximately 30 times the maiunum recommended human dose. In r/wmutagenidty studies were negative.
Pngiuqr. Pregnancy Category C Niledipinermlwnshowniobeleratogeniclnratsandembryotoxcin rau. mice and rabbits There are no adequate and well controlled studies in pregnant women PROCARDfA should be used duringpregnancy only II the potential beneUt )ustl8es the potential risk lo the tears ADVERSE REACTKMI: Tne most common adverse events include dizziness or llghtheadedness, peripheral edema, nausea, weakness, headache and Pushing, each occurring In about 10% ot patients, Iransienl hypotension In about 5%, palpitation in about 2% and syncope In about 0 5% Syncopal episodes did not recur with reduction In the dose ol PROCAROIA or concomUanl anllanglnal medication. Additionally, the lollming have a, nasal a * * * * been reporled muscle cramps, nervousness, dyspnea, il and chest congestion, shortness ot breath, diarrhea, cosstipalion, gastrointestinal cramps. Oaaience, Inlbmmallon. H»ri stiffness, shak'mess. iitterlness, sleep disturbances Murred vision, difficulties ia balance. dermalHis, pruritus, urticaria, trrer. sweating, chills, sexual diltcullro. liuombocytopenia, anemia, ttutopenia, purpura, allergic hepatitis, glnglval hyperptasia, depression, paranoid syndrome, transient Mlndntss at the peak of plasma tevef. erythrometilpla, and arthritis wWiANA( + ) \toywely.irttoduaionolPRO(>ROUItarapywasassocia1edwithaniricreasemarig^^n. possrbh; due to associated hypotension.
In addition, more serious adverse events were observed, no) readily distinguishable from the natural history of the disease In these patients U remains possiblt, however, thai some or many of thtse eveofs were drug refated Uyoordial Infarction occurred in about 4% ol patients and congestive heart lalluri or pulmonary edema In about 2% Ventricular trrhythmiu w conduction disturbances each occurred in lewer than 0 5% of pattern WJW tUKUED: PROCAROIA son gelatin capsofes are supplied In. Sheraton-National Airport Hotel Washington, DC The objective of this workshop is to bring together investigators in the fields of lipid metabolism/atherosclerosis research with those in thrombosis/hemostasis. Thirty experts will critically review newly emerging relationships among hypertriglyceridemia, arteriosclerosis, and thrombosis, and the potential molecular and cellular mechanisms that appear to be responsible for these relationships. Ample time will be allowed for audience participation in discussions and formulation of research recommendations to the NHLBI.
There is no registration fee; however, enrollment is limited. A block of rooms at reasonable rates will be available for workshop participants.
For further information and/or registration, please contact Sandra H. 
